Depletion of naive T cells using clinical grade magnetic CD45RA beads: A new approach for GVHD prophylaxis

Bone Marrow Transplantation

Volumn 49, Issue 1, 2014, Pages 138-144

  Teschner, D ^a   Distler, E ^a   Wehler, D ^a   Frey, M ^a   Marandiuc, D ^a   Langeveld, K ^b   Theobald, M ^a   Thomas, S ^a   Herr, W ^a,c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b MILTENYI BIOTEC GMBH   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Alloreactivity; CD45RA; GVHD; Memory; Naive; T cells

Indexed keywords

CD45RA ANTIGEN; GAMMA INTERFERON;

ADULT; ALLOIMMUNITY; ARTICLE; ASPERGILLUS FUMIGATUS; BASE MISPAIRING; CANDIDA ALBICANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CELL FUNCTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EFFECTOR CELL; ENZYME RELEASE; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; LYMPHOCYTE DEPLETION; MALE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; T LYMPHOCYTE; YOUNG ADULT;

ADULT; ANTIGENS, CD45; ANTIGENS, NEOPLASM; ASPERGILLUS; CANDIDA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOMAGNETIC SEPARATION; IMMUNOPHENOTYPING; INTERFERON-GAMMA; LEUKAPHERESIS; LYMPHOCYTE DEPLETION; MALE; T-LYMPHOCYTES;

EID: 84891879318     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.114     Document Type: Article

References (25)

1. Mielke S, Solomon SR, Barrett AJ. Selective depletion strategies in allogeneic stem cell transplantation. Cytotherapy 2005; 7: 109-115.
2. Handgretinger R. Negative depletion of CD3(+) and TcRalphabeta(+) T cells. Curr Opin Hematol 2012; 19: 434-439.
3. Meyer RG, Britten CM, Wehler D, Bender K, Hess G, Konur A et al. Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reducedintensity transplantation. Blood 2007; 109: 374-382.
4. Foster AE, Marangolo M, Sartor MM, Alexander SI, Hu M, Bradstock KF et al. Human CD62L-memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion. Blood 2004; 104: 2403-2409.
5. Chen BJ. Allogeneic memory T cell response. Biol Blood Marrow Transplant 2008; 14: 20-22.
6. Distler E, Bloetz A, Albrecht J, Asdufan S, Hohberger A, Frey M et al. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells. Haematologica 2011; 96: 1024-1032.
7. Kleemann P, Distler E, Wagner EM, Thomas S, Klobuch S, Aue S et al. Varicellazoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation. Haematologica 2012; 97: 874-882.
8. Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, Sansoni P et al. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech Ageing Dev 1996; 86: 173-195.
9. Appay V, van Lier RA, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008; 73: 975-983.
10. Hoffmann P, Eder R, Boeld TJ, Doser K, Piseshka B, Andreesen R et al. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108: 4260-4267.
11. Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 2010; 115: 3861-3868.
12. Cobbold M, Khan N, Pourgheysari B, Tauro S, McDonald D, Osman H et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005; 202: 379-386.
13. Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116: 4360-4367.
14. Waanders MM, Roelen DL, Brand A, Claas FH. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Transfus Med Rev 2005; 19: 281-287.
15. Joshi SK, Suresh PR, Chauhan VS. Flexibility in MHC and TCR recognition: degenerate specificity at the T cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology. J Immunol 2001; 166: 6693-6703.
16. Burrows SR, Khanna R, Burrows JM, Moss DJ. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 1994; 179: 1155-1161.
17. Amir AL, D'Orsogna LJ, Roelen DL, van Loenen MM, Hagedoorn RS, de Boer R et al. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 2010; 115: 3146-3157.
18. Nonn M, Herr W, Khan S, Todorova M, Link I, Thies J et al. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering. Transplantation 2008; 86: 1427-1435.
19. Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Lienard D, Lejeune F et al. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 1999; 190: 705-715.
20. Distler E, Wolfel C, Kohler S, Nonn M, Kaus N, Schnurer E et al. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice. Exp Hematol 2008; 36: 451-463.
21. Albrecht J, Frey M, Teschner D, Carbol A, Theobald M, Herr W et al. IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype. Cancer Immunol Immunother 2011; 60: 235-248.
22. Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T et al. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 2010; 115: 4923-4933.
23. Jedema I, van de Meent M, Pots J, Kester MG, van der Beek MT, Falkenburg JH. Successful generation of primary virus-specific and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells. Haematologica 2011; 96: 1204-1212.
24. Dutt S, Baker J, Kohrt HE, Kambham N, Sanyal M, Negrin RS et al. CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD. Blood 2011; 117: 3230-3239.
25. Rezvani K. Peptide vaccine therapy for leukemia. Int J Hematol 2011; 93: 274-280.